Top 10 U.S. Biopharma Clusters 2026 (opens in new tab)
Mid-cap buyers, improved capital raising climate, and reshoring of manufacturing are shaping how much and where biopharmas choose to grow. The post appeared first on .
Read the original articleMid-cap buyers, improved capital raising climate, and reshoring of manufacturing are shaping how much and where biopharmas choose to grow. The post appeared first on .
Read the original article